BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Aspira Pathlab & Diagnostics Ltd Industry :  Healthcare
BSE Code
540788
ISIN Demat
INE500C01017
Book Value (Rs)
11.8847761
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
98
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
10
Back
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.69 crore in the March 2026 quarter
25-May-26   Hrs IST

Net loss of Aspira Pathlab & Diagnostics reported to Rs 0.69 crore in the quarter ended March 2026 as against net profit of Rs 0.72 crore during the previous quarter ended March 2025. Sales rose 12.80% to Rs 6.52 crore in the quarter ended March 2026 as against Rs 5.78 crore during the previous quarter ended March 2025.

For the full year,net profit declined 97.58% to Rs 0.05 crore in the year ended March 2026 as against Rs 2.07 crore during the previous year ended March 2025. Sales rose 13.55% to Rs 24.98 crore in the year ended March 2026 as against Rs 22.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.525.78 13 24.9822.00 14
OPM %-5.0618.17 -5.8416.00 -
PBDT-0.291.09 PL 1.593.56 -55
PBT-0.690.72 PL 0.052.07 -98
NP-0.690.72 PL 0.052.07 -98

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)